Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic.
作者信息
Mendelsohn John
机构信息
The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
出版信息
Cancer Immunol Immunother. 2003 May;52(5):342-6. doi: 10.1007/s00262-002-0354-7. Epub 2003 Mar 14.
Abstract
摘要
相似文献
1
Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic.抗体介导的表皮生长因子受体阻断作为一种抗癌疗法：从实验室到临床
Cancer Immunol Immunother. 2003 May;52(5):342-6. doi: 10.1007/s00262-002-0354-7. Epub 2003 Mar 14.
2
Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.抗表皮生长因子受体抗体在转移性结直肠癌治疗中的应用
Clin Colorectal Cancer. 2004 Sep;4(3):159-62. doi: 10.1016/s1533-0028(11)70113-x.
3
The ErbB receptors as targets for breast cancer therapy.作为乳腺癌治疗靶点的表皮生长因子受体
J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):337-51. doi: 10.1023/a:1018762216147.
4
[Molecular target therapy for colonic neoplasms].[结肠肿瘤的分子靶向治疗]
Nihon Naika Gakkai Zasshi. 2007 Feb 10;96(2):289-94. doi: 10.2169/naika.96.289.
5
Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.一种用于癌症治疗的人抗表皮生长因子受体单克隆抗体的双重作用模式。
J Immunol. 2004 Oct 1;173(7):4699-707. doi: 10.4049/jimmunol.173.7.4699.
6
Role of an anti-epidermal growth factor receptor in treating cancer.抗表皮生长因子受体在癌症治疗中的作用。
Cancer Metastasis Rev. 1999;18(4):427-36. doi: 10.1023/a:1006302101468.
7
Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.对表皮生长因子受体抑制剂的敏感性和耐药性：增强表皮生长因子受体抗体疗效的方法。
MAbs. 2009 Nov-Dec;1(6):590-9. doi: 10.4161/mabs.1.6.10051. Epub 2009 Nov 11.
8
Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer.单克隆抗体作为头颈癌放疗和化疗的增效剂
Curr Opin Oncol. 1999 May;11(3):187-90. doi: 10.1097/00001622-199905000-00009.
9
Jeremiah Metzger Lecture. Targeted cancer therapy.耶利米·梅茨格讲座。靶向癌症治疗。
Trans Am Clin Climatol Assoc. 2000;111:95-110; discussion 110-1.
10
[New developments in immunotherapy for digestive system diseases].[消化系统疾病免疫治疗的新进展]
Nihon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1901-7. doi: 10.2169/naika.94.1901.
引用本文的文献
1
Evaluating the efficacy of the anticancer drug cetuximab by atomic force microscopy.通过原子力显微镜评估抗癌药物西妥昔单抗的疗效。
RSC Adv. 2018 Jun 13;8(39):21793-21797. doi: 10.1039/c8ra03215g.
2
Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma.抑制的OGT表达抑制肾细胞癌中的细胞增殖并调节EGFR表达。
Cancer Manag Res. 2019 Mar 19;11:2215-2223. doi: 10.2147/CMAR.S190642. eCollection 2019.
3
Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.与小分子多酚化合物霍诺因联合克服西妥昔单抗耐药性
Mol Cancer Ther. 2018 Jan;17(1):204-214. doi: 10.1158/1535-7163.MCT-17-0384. Epub 2017 Oct 20.
4
Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.通过分子对接鉴定出的靶向白血病细胞中翻译控制肿瘤蛋白的肽适配体。
Invest New Drugs. 2016 Aug;34(4):515-21. doi: 10.1007/s10637-016-0339-6. Epub 2016 Mar 14.
5
Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.肺癌衍生表皮生长因子受体突变体对西妥昔单抗的反应与非对称二聚化有关。
Cancer Res. 2013 Nov 15;73(22):6770-9. doi: 10.1158/0008-5472.CAN-13-1145. Epub 2013 Sep 24.
6
Evaluation of current methods to detect the mutations of epidermal growth factor receptor in non-small cell lung cancer patients.评估检测非小细胞肺癌患者表皮生长因子受体突变的现有方法。
Multidiscip Respir Med. 2012 Dec 11;7(1):52. doi: 10.1186/2049-6958-7-52.
7
Receptor-based virtual screening of EGFR kinase inhibitors from the NCI diversity database.基于受体的 NCI 多样性数据库中表皮生长因子受体激酶抑制剂的虚拟筛选。
Molecules. 2010 Jun 4;15(6):4041-54. doi: 10.3390/molecules15064041.
8
ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.雌激素受体α阴性和三阴性乳腺癌：分子特征与潜在治疗方法
Biochim Biophys Acta. 2009 Dec;1796(2):162-75. doi: 10.1016/j.bbcan.2009.06.003. Epub 2009 Jun 13.
9
Immunotherapy for head and neck cancer.头颈部肿瘤的免疫治疗。
Oral Oncol. 2009 Sep;45(9):747-51. doi: 10.1016/j.oraloncology.2009.02.009. Epub 2009 May 12.
10
Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.肺癌进展过程中表皮生长因子受体（EGFR）信号传导失调：突变、扩增子与自分泌环
Cancer Prev Res (Phila). 2008 Aug;1(3):156-60. doi: 10.1158/1940-6207.CAPR-08-0080.
Zotero 插件